当前位置: 首页 >> 检索结果
共有 1481 条符合本次的查询结果, 用时 2.6324337 秒

1. Hospitals' Patterns of Use of Noninvasive Ventilation in Patients With Asthma Exacerbation.

作者: Mihaela S Stefan.;Brian H Nathanson.;Aruna Priya.;Penelope S Pekow.;Tara Lagu.;Jay S Steingrub.;Nicholas S Hill.;Robert J Goldberg.;David M Kent.;Peter K Lindenauer.
来源: Chest. 2016年149卷3期729-36页
Limited data are available on the use of noninvasive ventilation in patients with asthma exacerbations. The objective of this study was to characterize hospital patterns of noninvasive ventilation use in patients with asthma and to evaluate the association with the use of invasive mechanical ventilation and case fatality rate.

2. Cardiac Dysfunction After Neurologic Injury: What Do We Know and Where Are We Going?

作者: Vijay Krishnamoorthy.;G Burkhard Mackensen.;Edward F Gibbons.;Monica S Vavilala.
来源: Chest. 2016年149卷5期1325-31页
Recent literature has implicated severe neurologic injuries, such as aneurysmal subarachnoid hemorrhage, as a cause of cardiac dysfunction, impaired hemodynamic function, and poor outcomes. Mechanistic links between the brain and the heart have been explored in detail over the past several decades, and catecholamine excess, neuroendocrine dysfunction, and unchecked inflammation all likely contribute to the pathophysiologic process. Although cardiac dysfunction has also been described in other disease paradigms, including septic shock and thermal injury, there is likely a common underlying pathophysiology. In this review, we will examine the pathophysiology of cardiac dysfunction after neurologic injury, discuss the evidence surrounding cardiac dysfunction after different neurologic injuries, and suggest future research goals to gain knowledge and improve outcomes in this patient population.

3. Outcomes of Nurse Practitioner-Delivered Critical Care: A Prospective Cohort Study.

作者: Janna S Landsperger.;Matthew W Semler.;Li Wang.;Daniel W Byrne.;Arthur P Wheeler.
来源: Chest. 2016年149卷5期1146-54页
Acute care nurse practitioners (ACNPs) are increasingly being employed in ICUs to offset physician shortages, but no data exist about outcomes of critically ill patients continuously cared for by ACNPs.

4. Crises in Sickle Cell Disease.

作者: Enrico M Novelli.;Mark T Gladwin.
来源: Chest. 2016年149卷4期1082-93页
In spite of significant strides in the treatment of sickle cell disease (SCD), SCD crises are still responsible for high morbidity and early mortality. While most patients initially seek care in the acute setting for a seemingly uncomplicated pain episode (pain crisis or vaso-occlusive crisis), this initial event is the primary risk factor for potentially life-threatening complications. The pathophysiological basis of these illnesses is end-organ ischemia and infarction combined with the downstream effects of hemolysis that results from red blood cell sickling. These pathological changes can occur acutely and lead to a dramatic clinical presentation, but are frequently superimposed over a milieu of chronic vasculopathy, immune dysregulation, and decreased functional reserve. In the lungs, acute chest syndrome is a particularly ominous lung injury syndrome with a complex pathogenesis and potentially devastating sequelae, but all organ systems can be affected. It is, therefore, critical to understand the SCD patients' susceptibility to acute complications and their risk factors so that they can be recognized promptly and managed effectively. Blood transfusions remain the mainstay of therapy for all severe acute crises. Recommendations and indications for the safest and most efficient implementation of transfusion strategies in the critical care setting are therefore presented and discussed, together with their pitfalls and potential future therapeutic alternatives. In particular, the importance of extended phenotypic red blood cell matching cannot be overemphasized, due to the high prevalence of severe complications from red cell alloimmunization in SCD.

5. Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts.

作者: Carlos H Martinez.;Alejandro A Diaz.;Amit D Parulekar.;Stephen I Rennard.;Richard E Kanner.;Nadia N Hansel.;David Couper.;Kristen E Holm.;Karin F Hoth.;Jeffrey L Curtis.;Fernando J Martinez.;Nicola A Hanania.;Elizabeth A Regan.;Robert Paine.;Christine T Cigolle.;MeiLan K Han.; .
来源: Chest. 2016年149卷4期927-35页
Younger persons with COPD report worse health-related quality of life (HRQL) than do older individuals. The factors explaining these differences remain unclear. The objective of this article was to explore factors associated with age-related differences in HRQL in COPD.

6. Relationship of Bisphosphonate Therapy and Atrial Fibrillation/Flutter: Outcomes of Sleep Disorders in Older Men (MrOS Sleep) Study.

作者: Samir R Thadani.;Bryan Ristow.;Terri Blackwell.;Reena Mehra.;Katie L Stone.;Gregory M Marcus.;Paul D Varosy.;Steven R Cummings.;Peggy M Cawthon.; .
来源: Chest. 2016年149卷5期1173-80页
Prior studies suggested an association between bisphosphonates and atrial fibrillation/flutter (AF) in women. This relationship in men, including those with sleep-disordered breathing (SDB), remains unclear. This study evaluated the relationship between bisphosphonate use and prevalent (nocturnal) and incident (clinically relevant) AF in a population of community-dwelling older men.

7. Error in Figure 1 in: Treatment and Prevention of Heparin-Induced Thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

来源: Chest. 2015年148卷6期1529页

8. Correction to Dosage in: Antiplatelet Drugs: Antithrombotic Therapy and Prevention of Thrombosis: 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

来源: Chest. 2015年148卷6期1529页

9. Development of Guidelines for the Management of Pulmonary Nodules: Toward Better Implementation.

作者: David R Baldwin.
来源: Chest. 2015年148卷6期1365-1367页

10. Response.

作者: David E Ost.
来源: Chest. 2015年148卷5期e161-e162页

11. The Weighty Issue of Obesity Management in Sleep Apnea.

作者: Sanjay R Patel.;Reena Mehra.
来源: Chest. 2015年148卷5期1127-1129页

12. Response.

作者: Tina Shah.;Matthew M Churpek.;Marcelo Coca Perraillon.;R Tamara Konetzka.
来源: Chest. 2015年148卷4期e134-e135页

13. Prostacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series.

作者: Catherine A Bonham.;Justin M Oldham.;Mardi Gomberg-Maitland.;Rekha Vij.
来源: Chest. 2015年148卷4期1055-1062页
It is unclear whether recent advances in pulmonary arterial hypertension therapy can be safely applied to sarcoidosis-associated pulmonary hypertension (SAPH). Evidence for prostacyclin (PG) therapy in SAPH is limited.

14. Response.

作者: Emanuele Pivetta.;Alberto Goffi.;Enrico Lupia.;Maria Tizzani.;Giulio Porrino.;Enrico Ferreri.;Giovanni Volpicelli.;Paolo Balzaretti.;Alessandra Banderali.;Antonello Iacobucci.;Stefania Locatelli.;Giovanna Casoli.;Michael B Stone.;Milena M Maule.;Ileana Baldi.;Franco Merletti.;Gian Alfonso Cibinel.; .
来源: Chest. 2015年148卷3期e96-e98页

15. Catheter-Directed Interventions for Acute Pulmonary Embolism: The Jury Is Still Out.

作者: Nathan L Liang.;Rabih A Chaer.;Efthymios D Avgerinos.
来源: Chest. 2015年148卷3期e93页

16. Who Gets Early Tracheostomy?: Evidence of Unequal Treatment at 185 Academic Medical Centers.

作者: Joshua J Shaw.;Heena P Santry.
来源: Chest. 2015年148卷5期1242-1250页
Although the benefits of early tracheostomy in patients dependent on ventilators are well established, the reasons for variation in time from intubation to tracheostomy remain unclear. We identified clinical and demographic disparities in time to tracheostomy.

17. Clinical Characteristics and Outcomes Are Similar in ARDS Diagnosed by Oxygen Saturation/Fio2 Ratio Compared With Pao2/Fio2 Ratio.

作者: Wei Chen.;David R Janz.;Ciara M Shaver.;Gordon R Bernard.;Julie A Bastarache.;Lorraine B Ware.
来源: Chest. 2015年148卷6期1477-1483页
Oxygen saturation as measured by pulse oximetry/Fio2 (SF) ratio is highly correlated with the Pao2/Fio2 (PF) ratio in patients with ARDS. However, it remains uncertain whether SF ratio can be substituted for PF ratio for diagnosis of ARDS and whether SF ratio might identify patients who are systemically different from patients diagnosed by PF ratio.

18. Pediatric Home Sleep Apnea Testing: Slowly Getting There!

作者: Hui-Leng Tan.;Leila Kheirandish-Gozal.;David Gozal.
来源: Chest. 2015年148卷6期1382-1395页
Pediatric OSA can result in significant neurocognitive, behavioral, cardiovascular, and metabolic morbidities. Prompt diagnosis and treatment are, therefore, of paramount importance. The current gold standard for diagnosis of OSA in children is in-laboratory polysomnography (PSG). Home sleep apnea testing has been considered as an alternative as it is potentially more cost effective, convenient, and accessible. This review concentrates mainly on the use of type 2 and 3 portable monitoring devices. The current evidence on the feasibility and diagnostic accuracy of home testing in the diagnosis of pediatric OSA was examined. Overall, the evidence in children is limited. Feasibility studies that have been performed have on the whole shown good results, with several reporting > 90% of their home recordings as meeting predetermined quality criteria regarding signal artifact and minimum recording time. The limited data comparing type 2 studies with in-laboratory PSG have shown no significant differences in respiratory parameters. The results pertaining to diagnostic accuracy of type 3 home sleep apnea testing devices are conflicting. Although more research is needed, home testing with at least a type 3 portable monitor offers a viable alternative in the diagnosis of otherwise healthy children with moderate to severe OSA, particularly in settings where access to polysomnography is scarce or unavailable. Of note, since most studies have been performed in habitually snoring healthy children, home sleep apnea testing may not be applicable to children with other comorbid conditions. In particular, CO2 monitoring is important in children in whom there is concern regarding nocturnal hypoventilation, such as children with neuromuscular disease, underlying lung disease, or obesity hypoventilation, and most home testing devices do not include a transcutaneous or end-tidal CO2 channel.

19. The Association Between Indwelling Arterial Catheters and Mortality in Hemodynamically Stable Patients With Respiratory Failure: A Propensity Score Analysis.

作者: Douglas J Hsu.;Mengling Feng.;Rishi Kothari.;Hufeng Zhou.;Kenneth P Chen.;Leo A Celi.
来源: Chest. 2015年148卷6期1470-1476页
Indwelling arterial catheters (IACs) are used extensively in the ICU for hemodynamic monitoring and for blood gas analysis. IAC use also poses potentially serious risks, including bloodstream infections and vascular complications. The purpose of this study was to assess whether IAC use was associated with mortality in patients who are mechanically ventilated and do not require vasopressor support.

20. Response.

作者: Meeta Prasad Kerlin.;Scott D Halpern.
来源: Chest. 2015年148卷2期e67-e68页
共有 1481 条符合本次的查询结果, 用时 2.6324337 秒